Mining pathway signatures from microarray data and relevant biological knowledge  by Panteris, Eleftherios et al.
Available online at www.sciencedirect.comwww.elsevier.com/locate/yjbin
Journal of Biomedical Informatics 40 (2007) 698–706Mining pathway signatures from microarray data
and relevant biological knowledge
Eleftherios Panteris *, Stephen Swift, Annette Payne, Xiaohui Liu
School of Information Systems, Computing and Mathematics, Brunel University, Uxbridge, Middlesex UB8 3PH, UK
Received 21 September 2006
Available online 22 February 2007Abstract
High-throughput technologies such as DNA microarray are in the process of revolutionising the way modern biological research is
being done. Bioinformatics tools are becoming increasingly important to assist biomedical scientists in their quest in understanding com-
plex biological processes. Gene expression analysis has attracted a large amount of attention over the last few years mostly in the form of
algorithms, exploring cluster and regulatory relationships among genes of interest, and programs that try to display the multidimensional
microarray data in appropriate formats so that they make biological sense. To reduce the dimensionality of microarray data and make
the corresponding analysis more biologically relevant, in this paper we propose a biologically-led approach to biochemical pathway anal-
ysis using microarray data and relevant biological knowledge. The method selects a subset of genes for each pathway that describes the
behaviour of the pathway at a given experimental condition, and transforms them into pathway signatures. The metabolic pathways of
Escherichia coli are used as a case study.
 2007 Elsevier Inc. All rights reserved.
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Microarrays have revolutionised biology as a science
and have ignited the bioinformatics revolution. The large
amount of data produced by microarray experiments
requires constant computational support in order to be of
any use. There has been a surge of activity since the early
days of bioinformatics to provide tools for the analysis of
microarray datasets using clustering techniques and later
on to describe the ﬁndings by applying modelling tech-
niques [1,2].
Motivated by the need in the bioinformatics area to
bridge the gap of communications between biology and
computer science [3–5] a new approach to pathway analysis
called Signature mining has been proposed. Signature
mining provides an analysis framework for microarray data
particularly developed for pathway analysis and more1532-0464/$ - see front matter  2007 Elsevier Inc. All rights reserved.
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is a summary measure of the relative expression of a path-
way in an experiment. It is created by taking a microarray
dataset and then overlaying it with metabolic pathway
information. By comparing gene proﬁles across many dif-
ferent experimental conditions, the most active genes per
pathway are found [6]. The combination of these active
genes produces a single summary measure for a pathway,
which is used to describe the state of that pathway, i.e.
its level of activity in any given experimental condition.
Common techniques currently used in the ﬁeld involve
the use of a single set of experiments and a metabolic data-
base, which is superimposed onto the data, graphically por-
traying the expression per experiment of each gene of the
pathway, leaving the researcher to decipher if the pathway
is active and to quantify the activity, based on the expres-
sions of a small number of genes per pathway. This ignores
the fact that many, sometimes most, genes can be members
of several pathways simultaneously. Pathway lists such as
KEGG [7] and EcoCyc [8] are veriﬁed and composed based
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clearly demonstrate that most genes are present in more
than one pathway, some in as many as seven or more
pathways.
The paper begins by describing the current methods
used in the area and outlines the reasons why we choose
a diﬀerent approach in Section 2. Section 3 details the pro-
posed algorithm for obtaining pathway signatures. Section
4 provides the experimental results for the pathway signa-
tures on several well known metabolic pathways. Section
5 summarises what has been achieved and suggests future
directions for this research.2. Motivation
Current pathway analysis methods of expression data,
which include all the current clustering techniques, require
all the genes of a pathway to be taken into account, and
may lead to the erroneous conclusion that the activity of
a pathway has remain unchanged. For example, if more
genes in a pathway are transcriptionally dormant than
transcriptionally active, the more numerous dormant ones
mask the true picture of a change in the activity of that
pathway.
Presently pathway regulation information is not explicit,
i.e. it does not specify if pathway A is categorically up reg-
ulated in experiment X by Y amount. Several attempts that
have been made in the literature include averaging gene
expression values of all the genes in the pathway or just
overlaying the gene expressions over the pathway outline
from pathway databases like KEGG [7] and EcoCyc [8],
which is common in most software tools available, such
as GenMAPP [9] Pathﬁnder [10], GScope [11] and Gene-
Net [12] to mention a few. These methods are not fully
addressing the issue; overlaying microarray data over path-
way maps from the KEGG database utilises visualisation
techniques to provide structural representation to the data
but with no added information on the pathway regulation.
Furthermore, using the average expression of all the
genes in a pathway works only on the assumption that
the genes are equally responsible for the ﬂow and rate of
the pathway something that is not true, especially if we
take into account the multiple memberships most genes
have, as our method does. Also by using the real or abso-
lute gene expression values to produce an average pathway
expression it is assumed that the pathway is the sum of its
parts, that is to say the resulting value is of a quantitative
not a qualitative description. This is a mistake that has led
to wrong conclusions before, as Ma and Zeng showed in
their paper [13], and we believe would happen again.
We believe that averaging pathway genes is biologically
inaccurate because it implies that the genes contribute
equally to the pathway workload and ﬂow, and more
importantly, that gene expression is translated directly into
a stoichiometric related metric, which is not the case. Gene
expression is an indication of behaviour of the cellularmachinery, active or dormant, and cannot be used as stoi-
chiometric measurements.
Another method that tries to provide answers in path-
ways analysis from the clustering point of view by trying
to match clusters of genes with functional similarities to
pathways is QPACA [14]. They are relying on the observa-
tion that only some experiments within a dataset are rele-
vant to a speciﬁc pathway and use this experiment to
recognise if subsets of genes are part of the same pathway
and further predict additional pathway members.
There are several assumptions here that are not in tune
with biological reasoning. It might well be that a pathway
is more active in a speciﬁc experiment, but that does not
mean that by choosing only that single experiment we
can draw conclusions from the measured gene expressions
of the genes as to the pathway they are members of and
new potential members to that pathway. It is well docu-
mented that microarray experiments often have artefacts
and false expression rates; the technology is not advanced
and accurate enough to ensure minimum error in both
the manufacturing and analysis of microarrays [1,2].
It is statistically reasonable and expected to use repli-
cated experiments to ensure validity of measurement but
due to well documented costs and time constrains most
datasets do not follow exactly these guidelines. Using a sin-
gle experiment do not give the ﬂexibility to check the
behaviour of the gene across diﬀerent experimental condi-
tions and the activities measured could be potentially inac-
curate. Furthermore, the methods of this kind does not
actually provide an answer to the question of pathway
behaviour since they are only interested in the structure
and discovery of new pathways which is exciting in itself
but not practical, considering the fact that the notion of
pathways is constantly challenged in the systems biology
area [3–5].
3. The methodology: from signature genes to pathway
signatures
Biochemical pathways are a rather eclectic collection of
genes that are diverse individually but function as unit. The
diversity of the genes in most pathways are profound, and
genes that code for proteins residing in the membrane of
the cell can be in the same pathway with genes that code
for transcription factors residing deep into the cell nucleus
[15]. Since pathways genes are diverse, they do not neces-
sarily have the same mode of action or response. That is
to say, a transmembrane protein will respond diﬀerently
from a transcription factor that is in the nucleus [15].
Utilising knowledge about biochemical pathways and
their components, we tried to produce a practical picture
of the behaviour of the metabolism of an organism based
on microarray data and pathway data from major dat-
abases like KEGG [7]. By collecting numerous experiments
from a given organism, Escherichia coli in this instance, for
distinct environmental conditions and treatments, and then
combining it with well-established pathway information
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subset of genes from each pathway, the signature genes,
which are used to describe the behaviour of that pathway
under the given condition.
The signature genes for each pathway are a unique sub-
set from the genes of a pathway that can be monitored in
any given microarray experiment to illustrate that path-
way’s behaviour. The signature genes are the ‘true’ expres-
sion indicators of the pathway. They are the most active
genes; hence they are the most sensitive part of the pathway
responding to external stimuli. Changes in the environmen-
tal conditions aﬀect signature genes in such a way as to alter
their expression in the cell more often. We believe that
these are the genes aﬀecting the function of the pathway
in a given experiment, so by monitoring them, and only
them, we can label the pathway as up-regulated, down-reg-
ulated or unchanged in the respective experiment. The rest
of the genes that constitute the pathway are transcription-
ally dormant, meaning, they do not show any ﬂuctuation in
expression across experiments, i.e. their transcript levels
remaining constant throughout a given condition. By con-
trast, the expression levels of active genes change often
throughout a given condition or between diﬀerent experi-
mental conditions. We believe that transcriptionally dor-
mant genes are not essential to the regulation of the
pathway but rather they provide the infrastructure that is
the structural network the pathway relies upon to function.
Monitoring the signature genes of a pathway in all sub-
sequent microarray experimental data would provide an
immediate description of the behaviour of the pathway
and subsequently of the whole organism in a global path-
way/signature network.
Our key emphasis lies on the utilisation of pathway
knowledge to group all the scattered genes in a microarray
dataset as pathways and monitor the pathway’s behaviour
as a whole, rather than genes individually. It is a diﬀerent
concept that aims to help biologists in pathway analysis,
by portraying microarray data in a pathway-orientated
view, with genes grouped not only by expression similarity
but also biologically.
3.1. The signature mining algorithm
In this section we present a framework that utilises
microarray data from genes with ﬂuctuating expression lev-
els to describe the state of the biochemical pathway they
belong to, at any given experimental condition. Our pro-
posed method extends the work presented at the IDAMAP
workshop [6] for which the following algorithm was sug-
gested to ﬁnd the best selection of genes in each pathway
that represent that pathway’s behaviour. This can be very
problematic because each gene can be a member of several
pathways and we needed to ﬁnd a way to choose genes that
represent each metabolic pathway in a dataset. Essentially
we tried to ﬁnd a way to move genes from one pathway to
another based on their similarity of expression for the
whole of the 51 experiments used (not just one experiment).Initially we opted for an algorithm with a hill climbing step
[18] described below.
3.1.1. Hill climbing step
Let G be the set of n genes, G = {1, . . .,n}, let X 2 RnT
be the n by T gene expression matrix for the n genes
where the ith row of X, xi, is the gene expression proﬁle
for gene i. xij is deﬁned as the jth element of the vector
xi. Let the pathway list P be a list of m > 0 lists where
pi ˝ G is the ith element of P, where |pi| > 0. A signature
si of a pathway pi is deﬁned as si ˝ pi, where ki is the size
of signature si. The list of signatures is denoted as S, where
|S| = m. sij is deﬁned as the jth element of the list si. How
close two expression proﬁles a and b are, is deﬁned as
follows:
dða; bÞ ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃXT
i¼1
ðxai  xbiÞ2
vuut ð1Þ
D 2 Rnn; where Dij ¼ dði; jÞ ð2Þ
The n by n symmetric matrix D contains all of the pair-wise
similarities between genes. Note that the larger d(a,b) is,
the more dissimilar the genes a and b are.
How close together the genes within a signature are is
deﬁned as follows:
FSðsiÞ ¼
Xki1
a¼1
Xki
b¼aþ1
dðsia; sibÞ ð3Þ
This is the sum of all pair-wise diﬀerences between the ele-
ments of a signature.
Eq. (4) represents how well ﬁtted the signatures are, and
Eq. (5) represents how many genes have been allocated
from each pathway. To ‘mine’ the signatures for each path-
way we need to ﬁnd a set S where F1 is minimised and F2 is
maximised:
F 1 ¼
Xm
i¼1
FSðsiÞ ð4Þ
F 2 ¼
Xm
i¼1
ki ð5Þ
F 3 ¼ F 1F 2 ð6Þ
The algorithm ﬁtness F3 is represented in Eq. (6) and needs
to be minimised for the optimum solution, i.e. the smallest
signature possible with the genes best describing the
pathway.
The signature mining algorithm takes as input a Euclid-
ean distance comparison matrix of all the genes from all the
pathways, and a pathway list of lists from KEGG [7] of all
the pathways and their genes. To mine the appropriate
genes for each signature, we decided to randomly remove
or replace a gene from a pathway and use a hill climbing
technique to evaluate the solution. The evaluation is based
on a similarity and a size function, requiring minimisation
of their fraction to progress.
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Since hill climbing is prone to local optima problems, we
recently improved the algorithm by transforming the hill
climbing step [17] into a simulated annealing one [19] with
visible improvements on the speed and performance of
the process along with comparisons between the two forms
of the algorithm [20].
The simulated annealing step is deﬁned with the equa-
tions below. In Eq. (7) the probability that a worst solution
is accepted is related to the diﬀerence between the solutions
Df and the starting temperature h0. The probability of a
worse solution being accepted at each iteration reduces as
the temperature cools (tends towards zero), as used in [21].
pr ¼ eDf ; Df ¼ f ðoldÞ  f ðnewÞ
h0
ð7Þ
e ¼ h0citer ð8Þ
c ¼ e
h0
 1=iter
ð9Þ
Since it is not possible to run the algorithm inﬁnitely we
choose the minimum temperature e Eq. (8) and in turn this
helps calculate the decay constant c Eq. (9) by which the
probability of accepting a worse solution is reduced in each
iteration. h0 = 1000, and e = 0.01 were used as starting val-
ues. The algorithm has a running time of 14 minutes in
MATLAB with 105 iterations.
3.2. The dataset
The data are from the Gene Expression Omnibus (GEO)
data repository at NCBI. The E. coli global experiments
represent three diﬀerent experimental conditions in 51 time
course experiments in total and contain the majority of the
known genes of the organism. The conditions are analysis
of changes in gene expression elicited by perturbations of
tryptophan metabolism using strains with mutations that
aﬀect tryptophan metabolism, analysis of the progression
of chromosomal replication forks in synchronized cells,
and time course of UV-responsive genes and their role in
cellular recovery [16]. The experimental data were norma-
lised to standard deviation of 1 and mean of 0 so that they
can be compared together. No further normalisation was
necessary since the data were already normalised to log
ratios when they were released in GEO [16].
The genes are chosen according to their variability in
expression and have to be above a certain global threshold
which is empirically deﬁned, as used in microarray analysis
[1,17] to be considered as statistically signiﬁcant. The
threshold is empirically selected depending on the dataset
used and is considered for each time point independently
and the selection process is repeated for every experiment.
The E. coli ﬁles were taken from the KEGG portal [7]. By
combining the two, a list of important genes was assembled
and these were used as the input to the algorithm.
As we wanted to get information about metabolic path-
ways through the genes we focused on metabolic relatedgenes. Using the pathway information available from
KEGG, we ﬁltered for genes that were on the metabolic
pathways only. This left 2220 genes out of about 4500
genes in total present in the database. From these 2220
genes, we further removed the genes that were under the
threshold of 1.4 we used. The 1430 genes left in our data,
were the genes that, more than once in the 51 experiments
their absolute expression was higher than the threshold.
We used these genes to ‘mine’ our signature genes.
For the current statistical analysis the ﬁrst experimental
condition which deals with tryptophan starvation is used.
The tryptophan starvation part of the dataset was used
for the statistical analysis of the pathway signatures. The
number of experiments was 18, from which the ﬁrst 8 were
experiments without tryptophan, with the remaining being
experiments in which tryptophan was slowly added to the
growth media. The other two conditions were not included
in the calculations for the correlation coeﬃcients since cor-
relation between pathways is only biologically relevant
only in comparable conditions.
4. Statistical analysis of signature results
4.1. Signature genes
The two versions of the algorithm have been used to
mine the signature genes from the phenylalanine, tyrosine
and tryptophan biosynthesis pathway, genes with known
behaviour from the experimental work of Khodursky
et al. [22]. The phenylalanine, tyrosine and tryptophan bio-
synthesis pathway includes genes from the biosynthesis of
these three amino acids. These three processes are grouped
together in the KEGG database due to the chemical simi-
larity these amino acids have, thus the pathway contains
26 genes from all three processes.
Both algorithms gave the same genes from the trypto-
phan pathway as signature genes, B1260 and B1261 [21].
Both were successful in identifying the key genes in the
pathway that are able to represent the behaviour shown
in Khodursky et al. [22]. The simulated annealing step
was, as expected, more accurate at pinpointing the genes
with the correct proﬁle by omitting genes with non-relevant
proﬁles than the hill climbing version where the signature
genes were included [21].
The signature genes were ‘mined’ from the GEO dataset
and applied to the Khodursky et al. [22] dataset. This is an
important fact to stress, since that shows that we can ﬁnd
genes that are controlling the expression of the pathway
using diﬀerent datasets and then use only these genes to
monitor the experiment at hand. The more extensive the
mining dataset the more precise the pinpointing of the sig-
nature genes of the pathways will become.
4.2. The pathway signatures
Here we show how the algorithm can be used on a large
scale where it is applied to the entirety of the metabolic
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described in the next section. The goal is to extract path-
way regulation information in a qualitative way. This is
done by taking into account the gene expression values
of all the signature genes we mined for a pathway, and
for each experiment/time point we choose the one that is,
in absolute terms, the highest value of gene expression
amongst them as the representative of the pathway’s
behavioural expression.
We believe that a signature gene with the absolute high-
est value is the bottleneck, the rate controller of the path-
way, thus by employing its expression we want to show
that the pathway behaves similarly, i.e. it is up or down
regulated at this point. The actual expression value is not
used as a quantitative measurement of activity because as
mentioned before we do not believe it makes biological
sense to directly connect gene expression with pathway
stoichiometry and rate of production.
Our value shows that the pathway is regulated up or
down relatively to the other pathways in the same experi-
ment since the data is already normalised for comparison.
Thus this value we use as a summary measure we term
pathway signature and we use it across the experimental
condition to give us the relative behaviour of each pathway
for the duration of the experiment.
To validate the pathway signatures from our framework,
we chose a variety of pathways that are biochemically
opposite in metabolism and plotted the pathway signature
for each experiment in the aforementioned datasets.
The results that follow demonstrate that pathway signa-
tures are valid biological representations of the pathway
behaviour. We took the biosynthesis and degradation path-
ways in metabolism of speciﬁc molecules and wanted to see
if their pathway signatures are as distinct and contra-regu-
lated as their pathways clearly are [15].
4.2.1. Phenylalanine, tyrosine and tryptophan, metabolic and
biosynthetic correlations
Biological knowledge dictates that biosynthetic and cat-
abolic pathways are distinct [15], i.e. they behave in a con-
tra manner to their counter-partners, so when the synthesis
of a molecule is up-regulated, and the degradation of the
substance is down-regulated.
As with previous work [6,21] the phenylalanine, tyrosine
and tryptophan biosynthesis pathway was initially chosen,
as deﬁned in the KEGG pathway database, and it is further
used to illustrate the biological validity of the method.
Khodursky et al. [22] have done microarray experiments
of E. coli under tryptophan starvation and by starving the
organism in their experiments; they monitored the activa-
tion of the aforementioned pathway. Fig. 1 above illus-
trates the fact by showing how diﬀerently the
biosynthesis and the metabolism of tryptophan behave as
shown by their pathway signatures. In this experimental
dataset, E. coli cells were grown without tryptophan so
they have to produce it. As a consequence the metabolism
of tryptophan and the other two amino acids that are madeby the pathway suppressed while the production is acti-
vated. The behaviour shown by the pathway signatures is
expected and has been well documented notably in Kho-
dursky et al. [22].
To further strengthen the point Table 1 gives the Pear-
son correlation values of the three pathway signatures and
Table 2 gives the Kendall’s tau b and Spearman correla-
tions as well. The correlations are all signiﬁcant at 1% level
and are 2-tailed. The Pearson correlations show the linear
relationship these pathways have, i.e. the direct inﬂuence
one has to the other.
We also chose the Spearman’s and Kendall’s tau b cor-
relation coeﬃcients to shown the non-linear relationships
between the pathways. As these are metabolic pathways,
which are in essence a very large network, many pathways
are inﬂuenced by proxy from others, and these two corre-
lation coeﬃcients are one way to measure this inﬂuence.
These statistical values show that the correlations
between the pathway signatures of these metabolic pro-
cesses are in tune with the biological roles of the pathways.
The phenylalanine, tyrosine and tryptophan biosynthesis
pathway shows a highly linear, negative relationship with
all three respective metabolic pathways and with a very
high signiﬁcance. Also bearing in mind that Spearman’s
and Kendall’s tau b show non-linear relationships, there
is strong non-linear negative correlation between the path-
ways suggesting that the pathways are in a reciprocal net-
work and not just in a linear path, which describes the
actual relationship of these pathways, evident in the
KEGG database [7].
This is one example of how the pathway signature can be
used as a valid, biological representation of a metabolic
pathway and how it can closely depict the real world rela-
tionship the metabolic pathway has with other metabolic
pathways in the same condition.
4.2.2. Statistical analysis of some representative E. coli
metabolic pathway signatures
The same statistical analysis was conducted for all avail-
able pathways, 103 in total. Below are some representative
metabolic pathways where they were chosen for their impor-
tance in metabolism and the fact that they have well docu-
mented connections and relationships with other pathways.
The pathways that are almost synonymous to metabo-
lism are of course glycolysis/gluconeogenesis, citrate cycle
(TCA), fatty acid biosynthesis and oxidative phosphoryla-
tion [15], see Fig. 2. Using their pathway signatures for fur-
ther statistical analysis the correlations show the strength
of their relationships both linearly and non-linearly. It is
interesting to note how signiﬁcant the correlations both lin-
ear and non-linear are, see Tables 3 and 4. Glycolysis
shows a higher and more signiﬁcant non linear than linear
correlation with the TCA cycle because pyruvate will even-
tually end up in the TCA cycle as a substrate but not
directly [15].
We can further see that the pathway signatures are
indeed a valid and easy pathway representation by showing
Fig. 1. The phenylalanine, tyrosine and tryptophan biosynthesis pathway signature, the pathway of which in this tryptophan starvation experiments is
switched on to produce tryptophan is in direct opposition with phenylalanine, tyrosine and tryptophan metabolic pathway signature, this is shown
graphically here.
Table 1
The Pearson correlation coeﬃcient of phenylalanine, tyrosine and tryptophan metabolic and phenylalanine, tyrosine and tryptophan biosynthesis (PTT)
pathway signatures
Tyrosine metabolism Phenylalanine metabolism Tryptophan metabolism PTT biosynthesis
Pearson correlation
Tyrosine metabolism 1 .905a .822a .882a
Phenylalanine metabolism .905a 1 .918a .987a
Tryptophan metabolism .822a .918a 1 .896a
PTT bioeynthesis .882a .987a .895a 1
a Correlation is signiﬁcant at the 1% level (2-tailed).
Table 2
Nonparametric correlation coeﬃcients of phenylalanine, tyrosine and tryptophan metabolic and phenylalanine, tyrosine and tryptophan (PTT)
biosynthesis pathway signatures
Tyrosine metabolism Phenylalanine metabolism Tryptophan metabolism PTT biosynthesis
Kendall’s tau b
Tyrosine metabolism 1 .752a .516a .569a
Phenylalanine metabolism .752a 1 .686a .582a
Tryptophan metabolism .516a .686a 1 .608a
PTT biosynthesis .569a .582a .608a 1
Spearman’s rho
Tyrosine metabolism 1 .903a .765a .798a
Phenylalanine metabolism .903a 1 .860a .796a
Tryptophan metabolism .765a .860a 1 .818a
PTT biosynthesis .798a .796a .818a 1
a Correlation is signiﬁcant at the 1% level (2-tailed).
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the purine and pyrimidine pathways together with the pen-
tose phosphate pathway and glutamate metabolism path-
way signatures in Fig. 3. These pathways are the
metabolic waste removers of the organism all related to
nitrogen metabolism and the removal of urea [15]. Tables
5 and 6 show again their statistical correlations, in all
accounts the correlation values are at statistically signiﬁ-
cant levels. Note especially the non linear correlations thatare indeed of very high signiﬁcance level between the pen-
tose phosphate and the glutamate pathway although their
linear relationship is not signiﬁcant enough.
Glutamate has a high linear relationship with pyrimi-
dine metabolism which in turn has a high linear relation-
ship with the pentose phosphate pathway, which explains
the non-linear relationship the correlations are showing is
a valid one and also goes some way to explain the similarity
of behaviour of the pathways, as seen in Fig. 3.
Fig. 2. The pathway signatures of glycolysis, TCA cycle, fatty acid biosynthesis and oxidative phosphorylation.
Table 3
The Pearson correlation coeﬃcients of the glycolysis/gluconeogenesis, TCA, fatty acid biosynthesis and oxidative phosphorylation pathway signatures
Glycolysis/
gluconeogenesis
Citrate cycle (TCA cycle) Fatty acid biosynthesis
(path 1)
Oxidative
phosphorylation
Pearson correlation
Glycolysis/gluconeogenesis 1 .547b .633a .612a
Citrate cycle (TCA cycle) .547b 1 .942a .897a
Fatty acid biosynthesis
(path1)
.633a .942a 1 .931a
Oxidative phosphorylation .612a .897a .931a 1
a Correlation is signiﬁcant at the 1% level (2-tailed).
b Correlation is signiﬁcant at the 5% level (2-tailed).
Table 4
The non-parametric correlation coeﬃcients of the glycolysis/gluconeogenesis, TCA, fatty acid biosynthesis and oxidative phosphorylation pathway
signatures
Glycolysis/
gluconeogenesis
Citrate cycle (TCA cycle) Fatty acid biosynthesis
(path 1)
Oxidative
phosphorylation
Kendall’s tau b
Glycolysis/gluconeogenesis 1 .490a .556a .490a
Citrate cycle (TCA cycle) .490a 1 .882a .817a
Fatty acid biosynthesis
(path1)
.556a .882a 1 .725a
Oxidative phosphorylation .490a .817a .725a 1
Spearman’s rho
Glycolysis/gluconeogenesis 1 .662a .744a .703a
Citrate cycle (TCA cycle) .662a 1 .969a .915a
Fatty acid biosynthesis
(path1)
.744a .969a 1 .876a
Oxidative phosphorylation .703a .915a .876a 1
a Correlation is signiﬁcant at the 1% level (2-tailed).
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sis and metabolic pathways as we know [15] and there are
numerous examples to further illustrate this.
The statistical analysis of the whole dataset has shown a
large number of correlations between the metabolic path-ways that for the most pathways are readily veriﬁable in
the KEGGS database. Further results were not shown
due to space limitations; however they all show that the
pathway signatures are indeed a valid way of portraying
metabolic pathways.
Fig. 3. The pathway signatures of the purine and pyrimidine pathways together with the pentose phosphate pathway and glutamate metabolism pathway
signatures. Their well documented relationships [7] are clearly shown here by the pathway signatures.
Table 5
The Pearson correlation coeﬃcients of the pentose phosphate, purine metabolism, pyrimidine metabolism and glutamate metabolism pathway signatures
Pentose phosphate pathway Purine metabolism Pyrimidine metabolism Glutamate metabolism
Pearson correlation
Pentose phosphate pathway 1 .605a .617a .361
Purine metabolism .605a 1 .595a .495a
Pyrimidine metabolism .617a .595a 1 .713a
Glutamate metabolism .361 .495b .713a 1
a Correlation is signiﬁcant at the 1% level (2-tailed).
b Correlation is signiﬁcant at the 5% level (2-tailed).
Table 6
The non-parametric correlation coeﬃcients of the pentose phosphate, purine, pyrimidine and glutamate metabolism pathway signatures
Pentose phosphate pathway Purine metabolism Pyrimidine metabolism Glutamate metabolism
Kendall’s tau b
Pentose phosphate pathway 1 .412b .425b .438b
Purine metabolism .412b 1 .464a .399b
Pyrimidine metabolism .425b .464a 1 .542a
Glutamate metabolism .438b .399b .542a 1
Spearman’s rho
Pentose phosphate pathway 1 .585b .680a .651a
Purine metabolism .585b 1 .577b .540b
Pyrimidine metabolism .680a .577b 1 .761a
Glutamate metabolism .651a .540b .761a 1
a Correlation is signiﬁcant at the 1% level (2-tailed).
b Correlation is signiﬁcant at the 5% level (2-tailed).
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5.1. Pathway signatures and systems biology
We have shown that the signaturemining framework is a
valuable tool for pathway analysis in biomedical research
due to its ability to portray all the metabolic pathways of
an organism in a single experiment providing at the same
time with deﬁnitive behavioural information. This is donenot only by ﬁnding the relevant genes in each pathway
but also by providing a single relative value for each path-
way that shows if the pathway is active, as well as by how
much compared to the others and whether it is up or down
regulation at the same time.
The researcher is able to see which pathways are
aﬀected in each experiment and how, following a speciﬁc
treatment, being a drug or a substance, the organism
responds. This we believe allows the scientist to make
706 E. Panteris et al. / Journal of Biomedical Informatics 40 (2007) 698–706valuable hypotheses on the way the organism reacts to a
speciﬁc course of treatment and show potential side eﬀects
by highlighting the pathways responsive to the treatment
for further tests.5.2. Pathway signatures
Our pathway signature has several advantages over other
methods, the most prominent being the deﬁnite answer to
the question ‘‘Is a pathway active and if yes is it up or down
regulated in a given experiment?’’ This is very important for
the scientist because it can provide a deﬁnite answer for all
the pathways in a set of experiments.
Another advantage, is that since we extracted a singular
value that describes the behaviour (we can term it relative
expression) of a pathway, we can apply common gene
expression techniques to further aid pathway analysis, i.e.
pathway signatures can be compared to each other to see
potential pathway coordinated behaviour that can mean
co-regulation or inverse relationships in pathways. In
essence our framework allows us to analyse microarray
data in modular ways and explore inter-pathway relation-
ships in a systems biology mindset.5.3. Future work
Future work includes the exploration of clustering tech-
niques in order to group the pathways in meaningfully
functional clusters to allow for systemic exploration of
metabolism, and identiﬁcation of new pathway members
from the large number of genes with unknown functions.
Also, a more formal analysis of the algorithm is planned
to establish areas that need optimisation. Furthermore,
applications of the algorithm will not be restricted to
E. coli but to other organisms with speciﬁc pharmaceutical
concerns and ultimately to human data, with a continua-
tion of the framework steps to include gene networks and
interactions with protein–protein networks, in order to
oﬀer a valid solution in that area of systems biology. The
algorithm m-ﬁles and links to the datasets used can be
found at http://people.brunel.ac.uk/~csstxhl/IDA/
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